The news of Raymond James maintaining its Outperform rating for Amerant Bancorp is positive for the company, but the lowering of the price target from $26 to $24 may have a neutralizing effect on the stock price in the short term. The shares are already trading down 1.29% at $19.57, and the new price target still represents a 22.67% increase from the current share price. The overall impact on the stock price is expected to be neutral in the short term.